Maria G. Rossino

Milan, 20122, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Journal: European journal of cancer (Oxford, England : 1990)
Published: July 14, 2026

Correction: The potential of Lisosan G as a possible treatment for glaucoma.

Correction: The potential of Lisosan G as a possible treatment for glaucoma.

Journal: Frontiers in pharmacology
Published: April 08, 2026

Comparative real-world progression free survival of CDK4/6 inhibitors in HR+/HER2- breast cancer patients with bone metastases.

Comparative real-world progression free survival of CDK4/6 inhibitors in HR+/HER2- breast cancer patients with bone metastases.

Journal: The oncologist
Published: June 13, 2025

Corrigendum to "Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response-the Neo-Runner study": [ESMO Open 9 (2024) 10.1016/j.esmoop.2024.103665].

Corrigendum to "Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response-the Neo-Runner study": [ESMO Open 9 (2024) 10.1016/j.esmoop.2024.103665].

Journal: ESMO open
Published: December 01, 2024

Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.

Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.

Journal: Breast (Edinburgh, Scotland)
Published: October 22, 2024

Postbiotics as Adjuvant Therapy in Cancer Care.

Postbiotics as Adjuvant Therapy in Cancer Care.

Journal: Nutrients
Published: June 04, 2024

Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response-the Neo-Runner study.

Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response-the Neo-Runner study.

Journal: ESMO open
Published: May 04, 2024

Oxaliplatin-Related Hypersensitivity Reactions: A Single Institution Series and Literature Review.

Oxaliplatin-Related Hypersensitivity Reactions: A Single Institution Series and Literature Review.

Journal: Biomedicines
Published: November 07, 2022

A Nature-Inspired Nrf2 Activator Protects Retinal Explants from Oxidative Stress and Neurodegeneration.

A Nature-Inspired Nrf2 Activator Protects Retinal Explants from Oxidative Stress and Neurodegeneration.

Journal: Antioxidants (Basel, Switzerland)
Published: July 08, 2021

The Potential of Lisosan G as a Possible Treatment for Glaucoma.

The Potential of Lisosan G as a Possible Treatment for Glaucoma.

Journal: Frontiers in pharmacology
Published: June 03, 2021

GPS-profiling of retrograde navigational impairments associated with hippocampal lesion in homing pigeons.

GPS-profiling of retrograde navigational impairments associated with hippocampal lesion in homing pigeons.

Journal: Behavioural brain research
Published: March 01, 2021

Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy.

Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy.

Journal: Cells
Published: May 10, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026